Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01797159 · ClinicalTrials.gov registry record · NA
Hippocampal Prophylactic Cranial Irradiation for Small Cell Lung Cancer
A NA study of Small-cell Lung Cancer and SCLC, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 2
- Study locations
NCT01797159 is a NA study of Small-cell Lung Cancer and SCLC that has completed, run by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. The registered enrollment target is 20 participants, below the 232-participant average among 79 other Small-cell Lung Cancer trials with a reported enrollment target (91% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT01797159, a NA study of Small-cell Lung Cancer and SCLC, has completed, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 2
- Study locations
Study Summary
The Investigators are looking to compare standard treatment for the management of small cell lung cancer (SCLC) which is prophylactic cranial Irradiation (PCI) (shown to be very good in patient survival) with cranial sparing PCI. Although standard of care PCI is successful in patient survival it also has neurologic side-effects. The Investigators are hoping the cranial sparing PCI has the same positive survival results with the added benefit of lowering neurological side-effects.
Conditions Studied
Interventions
- RADIATION Hippocampal-sparing Prophylactic Cranial Irradiation
Study Locations (2)
Maryland
- Bayview Medical Center - Baltimore
- The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2013-03-11 |
| Est. Completion | 2019-03-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01797159
The ClinicalTrials.gov registry entry for NCT01797159 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 232-participant average among 79 other Small-cell Lung Cancer trials with a reported enrollment target (91% lower). The listed sponsor is Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, which has 523 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Small-cell Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which Hippocampal-sparing Prophylactic Cranial Irradiation is the first listed.
NCT01797159 reports 2 study locations spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT01797159 about?
NCT01797159 is a clinical study titled "Hippocampal Prophylactic Cranial Irradiation for Small Cell Lung Cancer". The Investigators are looking to compare standard treatment for the management of small cell lung cancer (SCLC) which is prophylactic cranial Irradiation (PCI) (shown to be very good in patient survival) with cranial sparing PCI. Although standard of care PCI is successful in patient survival it als...
What is the current status of trial NCT01797159?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2013-03-11. Estimated completion is 2019-03-18.
What conditions does trial NCT01797159 study?
This clinical trial studies the following conditions: Small-cell Lung Cancer, SCLC, Small Cell Lung Cancer Limited Stage.
What interventions are being tested in trial NCT01797159?
The interventions under investigation include: Hippocampal-sparing Prophylactic Cranial Irradiation (RADIATION).
Who is sponsoring clinical trial NCT01797159?
This trial is sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, which has 523 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01797159 being conducted?
This trial has 2 study locations across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Small-cell Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of Hospital-at-Home for People Receiving Tarlatamab
RECRUITING · NA
-
Prospective Study of Intensity-Modulated Proton Therapy (IMPT) for Small Cell Lung Cancer
RECRUITING · NA
-
LOcally ABLatIve ThErapy for OligopRogressive Lung And Thoracic MalignanciEs (OBLITERATE)
RECRUITING · NA
-
Comparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving Immunotherapy
RECRUITING · NA
-
Stereotactic Radiation in Patients With Small Cell Lung Cancer and 1-10 Brain Metastases
ACTIVE NOT RECRUITING · NA
-
A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.